Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
This study is currently recruiting patients.
Sponsored by: | Walter Reed Army Institute of Research (WRAIR)
GlaxoSmithKline
|
---|---|
Information provided by: | Walter Reed Army Institute of Research (WRAIR) |
Purpose
This is a double blinded study where 2 test vaccines will be evaluated to see if they protect persons who have never had malaria against malaria infection when bitten by mosquitoes.
Condition | Treatment or Intervention | Phase |
---|---|---|
Malaria |
Vaccine: RTS,S with AS02A/AS01B adjuvant |
Phase I Phase II |
MedlinePlus related topics: Malaria
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Active Control, Single Group Assignment, Safety/Efficacy Study
Expected Total Enrollment: 104
Study start: December 2003
Eligibility
Ages Eligible for Study: 18 Years - 45 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Location and Contact Information
More Information
Clinical Trials Center website
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |